We build breakthrough biotechs

Biotech

Creating and building breakthrough biotechs for over 30 years

People

Partnering with the world's best life science entrepreneurs

Impact

Translating groundbreaking science into life-changing medicines
Scroll to explore
3
Latest news
Novartis Buys Mariana Oncology in $1B Acquisition, Bolsters Radiopharma Assets
Find out more
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
Find out more
Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing
Find out more

Thirty years at the leading-edge of medical innovation and we’re just getting started.

~ Measuring our impact

>25

Medicines made by Atlas portfolio companies

~ Measuring our impact

70

Startups launched from the Atlas incubator

~ Measuring our impact

40

IPOs

~ Measuring our impact

34

M&A Exits